1,338
Views
8
CrossRef citations to date
0
Altmetric
Report

An efficient method for variable region assembly in the construction of scFv phage display libraries using independent strand amplification

, , , , , , & show all
Pages 542-550 | Published online: 01 Jul 2012

References

  • Brekke OH, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003; 2:52 - 62; http://dx.doi.org/10.1038/nrd984; PMID: 12509759
  • Brennan DJ, O’Connor DP, Rexhepaj E, Ponten F, Gallagher WM. Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat Rev Cancer 2010; 10:605 - 17; http://dx.doi.org/10.1038/nrc2902; PMID: 20720569
  • Chan CE, Chan AH, Hanson BJ, Ooi EE. The use of antibodies in the treatment of infectious diseases. Singapore Med J 2009; 50:663 - 72, quiz 673; PMID: 19644620
  • Huber M, Olson WC, Trkola A. Antibodies for HIV treatment and prevention: window of opportunity?. Curr Top Microbiol Immunol 2008; 317:39 - 66; http://dx.doi.org/10.1007/978-3-540-72146-8_2; PMID: 17990789
  • Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia. Drugs 2003; 63:803 - 43; http://dx.doi.org/10.2165/00003495-200363080-00005; PMID: 12662126
  • Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344:783 - 92; http://dx.doi.org/10.1056/NEJM200103153441101; PMID: 11248153
  • Aybay C, Ozel S, Aybay C. Demonstration of specific antibodies against infliximab induced during treatment of a patient with ankylosing spondylitis. Rheumatol Int 2006; 26:473 - 80; http://dx.doi.org/10.1007/s00296-005-0085-0; PMID: 16341700
  • Hwang WY, Foote J. Immunogenicity of engineered antibodies. Methods 2005; 36:3 - 10; http://dx.doi.org/10.1016/j.ymeth.2005.01.001; PMID: 15848070
  • Tjandra JJ, Ramadi L, McKenzie IF. Development of human anti-murine antibody (HAMA) response in patients. Immunol Cell Biol 1990; 68:367 - 76; http://dx.doi.org/10.1038/icb.1990.50; PMID: 1711007
  • Gavilondo JV, Larrick JW. Antibody engineering at the millennium. Biotechniques 2000; 29:128-32, 34-6, 38 passim.
  • Lonberg N. Human antibodies from transgenic animals. Nat Biotechnol 2005; 23:1117 - 25; http://dx.doi.org/10.1038/nbt1135; PMID: 16151405
  • Bradbury AR, Sidhu S, Dübel S, McCafferty J. Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol 2011; 29:245 - 54; http://dx.doi.org/10.1038/nbt.1791; PMID: 21390033
  • Rau R. Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Ann Rheum Dis 2002; 61:Suppl 2 ii70 - 3; PMID: 12379628
  • Finlay WJ, Cunningham O, Lambert MA, Darmanin-Sheehan A, Liu X, Fennell BJ, et al. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions. J Mol Biol 2009; 388:541 - 58; http://dx.doi.org/10.1016/j.jmb.2009.03.019; PMID: 19285987
  • Gram H, Marconi LA, Barbas CF 3rd, Collet TA, Lerner RA, Kang AS. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci U S A 1992; 89:3576 - 80; http://dx.doi.org/10.1073/pnas.89.8.3576; PMID: 1565653
  • Jung S, Honegger A, Plückthun A. Selection for improved protein stability by phage display. J Mol Biol 1999; 294:163 - 80; http://dx.doi.org/10.1006/jmbi.1999.3196; PMID: 10556036
  • Lippow SM, Wittrup KD, Tidor B. Computational design of antibody-affinity improvement beyond in vivo maturation. Nat Biotechnol 2007; 25:1171 - 6; http://dx.doi.org/10.1038/nbt1336; PMID: 17891135
  • Wu H, Beuerlein G, Nie Y, Smith H, Lee BA, Hensler M, et al. Stepwise in vitro affinity maturation of Vitaxin, an alphav beta3-specific humanized mAb. Proc Natl Acad Sci U S A 1998; 95:6037 - 42; http://dx.doi.org/10.1073/pnas.95.11.6037; PMID: 9600913
  • Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005; 23:1126 - 36; http://dx.doi.org/10.1038/nbt1142; PMID: 16151406
  • Le Gall F, Kipriyanov SM, Moldenhauer G, Little M. Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding. FEBS Lett 1999; 453:164 - 8; http://dx.doi.org/10.1016/S0014-5793(99)00713-9; PMID: 10403395
  • Müller D, Kontermann RE. Bispecific antibodies for cancer immunotherapy: Current perspectives. BioDrugs 2010; 24:89 - 98; http://dx.doi.org/10.2165/11530960-000000000-00000; PMID: 20199124
  • Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228:1315 - 7; http://dx.doi.org/10.1126/science.4001944; PMID: 4001944
  • Bradbury AR, Marks JD. Antibodies from phage antibody libraries. J Immunol Methods 2004; 290:29 - 49; http://dx.doi.org/10.1016/j.jim.2004.04.007; PMID: 15261570
  • McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348:552 - 4; http://dx.doi.org/10.1038/348552a0; PMID: 2247164
  • Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994; 13:3245 - 60; PMID: 8045255
  • Knappik A, Ge L, Honegger A, Pack P, Fischer M, Wellnhofer G, et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol 2000; 296:57 - 86; http://dx.doi.org/10.1006/jmbi.1999.3444; PMID: 10656818
  • Söderlind E, Strandberg L, Jirholt P, Kobayashi N, Alexeiva V, Aberg AM, et al. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat Biotechnol 2000; 18:852 - 6; http://dx.doi.org/10.1038/78458; PMID: 10932154
  • Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991; 222:581 - 97; http://dx.doi.org/10.1016/0022-2836(91)90498-U; PMID: 1748994
  • Sheets MD, Amersdorfer P, Finnern R, Sargent P, Lindquist E, Schier R, et al. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci U S A 1998; 95:6157 - 62; http://dx.doi.org/10.1073/pnas.95.11.6157; PMID: 9600934
  • Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 1996; 14:309 - 14; http://dx.doi.org/10.1038/nbt0396-309; PMID: 9630891
  • Sblattero D, Bradbury A. Exploiting recombination in single bacteria to make large phage antibody libraries. Nat Biotechnol 2000; 18:75 - 80; http://dx.doi.org/10.1038/71958; PMID: 10625396
  • Barbas CF Phage display: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001.
  • Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989; 77:61 - 8; http://dx.doi.org/10.1016/0378-1119(89)90359-4; PMID: 2744488
  • Retter I, Althaus HH, Münch R, Müller W. VBASE2, an integrative V gene database. Nucleic Acids Res 2005; 33:Database issue D671 - 4; http://dx.doi.org/10.1093/nar/gki088; PMID: 15608286
  • Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389 - 402; http://dx.doi.org/10.1093/nar/25.17.3389; PMID: 9254694
  • Davidkova G, Pettersson S, Holmberg D, Lundkvist I. Selective usage of VH genes in adult human B lymphocyte repertoires. Scand J Immunol 1997; 45:62 - 73; http://dx.doi.org/10.1046/j.1365-3083.1997.d01-376.x; PMID: 9010502
  • Pansri P, Jaruseranee N, Rangnoi K, Kristensen P, Yamabhai M. A compact phage display human scFv library for selection of antibodies to a wide variety of antigens. BMC Biotechnol 2009; 9:6; http://dx.doi.org/10.1186/1472-6750-9-6; PMID: 19175944
  • Aitken R Antibody phage display: methods and protocols. Dordrecht; New York: Humana Press, 2009.
  • Clackson T. Lowman HB Phage display: a practical approach. Oxford: Oxford University Press, 2004.
  • O'Brien PM. Aitken R Antibody phage display: methods and protocols. Totowa, N.J.: Humana Press, 2002.
  • Okamoto T, Mukai Y, Yoshioka Y, Shibata H, Kawamura M, Yamamoto Y, et al. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen. Biochem Biophys Res Commun 2004; 323:583 - 91; http://dx.doi.org/10.1016/j.bbrc.2004.08.131; PMID: 15369791
  • Glanville J, Zhai W, Berka J, Telman D, Huerta G, Mehta GR, et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci U S A 2009; 106:20216 - 21; http://dx.doi.org/10.1073/pnas.0909775106; PMID: 19875695
  • Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 2010; 9:767 - 74; http://dx.doi.org/10.1038/nrd3229; PMID: 20811384
  • Baldwin JP, Boseley PG, Bradbury EM, Ibel K. The subunit structure of the eukaryotic chromosome. Nature 1975; 253:245 - 9; http://dx.doi.org/10.1038/253245a0; PMID: 1167623
  • Aguillón J, Ramos R, Chiong M, Vallejos P, Ferreira A. Soybean proteins: alternative blocking agents for immunoassays using nitrocellulose or plastic solid phases. Biol Res 1992; 25:79 - 83

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.